If you need more lookups,
subscriptions start at $34 USD/month.
Scott Coleman Location
Lexington, MA, US
Scott Coleman Work
Chief Development Officer (CDO) @ (August 2023 - Present)
Senior Vice President Nonclinical Development @ (June 2022 - Present)
Vice President Nonclinical Development @ (January 2020 - May 2022)
Senior Director Preclinical Safety Evaluation @ (January 2018 - January 2020)
Head of Nonclinical Development @ (September 2015 - January 2018)
Senior Director - Discovery Toxicology and DMPK @ (January 2015 - May 2015)
Senior Director - Discovery Toxicology and DMPK @ Cubist Pharmaceuticals (September 2011 - January 2015)
Director - Discovery Toxicology and DMPK @ Cubist Pharmaceuticals (September 2008 - September 2011)
Senior Scientist @ Cubist Pharmaceuticals (September 2006 - September 2008)
Senior Scientist @ Millennium Pharmaceuticals (January 2001 - September 2006)
Scott Coleman Education
North Carolina State University
Doctor of Philosophy (Toxicology)
1996-2000
Northeastern University
Bachelor of Science (Toxicology)
1988-1993
University of Massachusetts Medical School
Scott Coleman Skills
Biotechnology
Cross Functional Team Leadership
Chromatography
R&d
EHS
Mobiles Marketing
Scott Coleman Summary
Scott Coleman, based in Lexington, MA, US, is currently a Chief Development Officer (CDO) at Xilio Therapeutics, Inc.. Scott Coleman brings experience from previous roles at Xilio Therapeutics, Inc., Acceleron Pharma and Spero Therapeutics. Scott Coleman holds a 1996 - 2000 Doctor of Philosophy in Toxicology @ North Carolina State University. With a robust skill set that includes Biotechnology, Cross Functional Team Leadership, Chromatography, R&d, EHS and more. Scott Coleman has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Scott Coleman?
Find contact details for 700 million professionals.